Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Shinobi Therapeutics develops immune-evasive iPS cell therapies for cancer treatment.
Nouscom is a biotech company that develops a series of immunotherapies that are capable of selectively killing tumor cells.
Phagenesis is engaged in the development of a device to treat dysphagia, a condition that disables the safe swallowing of food.
Onera Health is a global leader in sleep diagnostics and monitoring.
LUMA Vision develops a 4D imaging and navigation end-to-end platform for cardiac applications, focusing on point-of-therapy data delivery.
VectorY is an integrated gene therapy company focused on development of therapeutics for CNS, somatic disorders and muscle diseases.
Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.
Xeltis is a clinical-stage medtech company with the world's most advanced polymer-based platform of restorative cardiovascular devices.
ViCentra has developed an insulin pump for diabetes patients.
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.
FoRx Therapeutics is a biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress pathways.
Noema Pharma is a biotech company that develops therapies to address disabling symptoms in conditions of the brain and nervous system.
Exciva develops clinical-stage biopharmaceutical therapies focused on addressing neuropsychiatric symptoms associated with dementia.
INNOVO by Atlantic Therapeutics is a medical technology firm that develops pelvic floor muscle strengthening and nerve stimulation products.
ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.
Artios Pharma is a biopharmaceutical company that provides new solutions in the DNA damage response (DDR) field.
Kinaset Therapeutics is a biopharma company that focuses on advancement of novel drugs in areas of unmet medical needs.
AstronauTx is a UCL spin-off, will develop medicines designed to reset the behaviour of astrocytes.
Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.
Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
Onward develops an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools.
Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications.
Cyted uses artificial intelligence (AI) and digital pathology to improve the detection and diagnosis of diseases, including cancer.
SNIPR Biome is a operator of a discovery stage biotech company intended to revolutionize the treatment of microbial diseases.
EQT Life Sciences has invested in 81 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
EQT Life Sciences's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Medical Device. The firm invests across 18 different industry categories.
Among tracked funding rounds, Tubulis received $400.6M in a Series C round. EQT Life Sciences's total known invested capital is $4.5B.
EQT Life Sciences's average investment size is $72.3M across its portfolio of 81 companies.
Recent EQT Life Sciences portfolio additions include Shinobi Therapeutics, Nouscom, Phagenesis, Onera Health, LUMA Vision. These companies were founded in 2020 or later.